|
¹ÙÀÌ¿ÀÀÌÁî |
QMÆÀ ¸ðÁý
¼¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
3³â¡è |
ä¿ë½Ã |
06.17 |
|
|
(ÁÖ)Á¦³ë½º |
Á¦³ë½º Ç°ÁúÆÀ QA(°æ·Â) / QC ½ÅÀÔ&°æ·Â ä¿ë
°æ±â ¼ö¿ø½Ã ¿µÅ뱸 | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.10 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Field medical, Dupilumab (Medical manage
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
10³â¡è |
ä¿ë½Ã |
11.08 |
|
|
¾Ë¸®ÄÚÁ¦¾à(ÁÖ) |
[°æ·Â] Á¦¾à Ç°Áú (QC) ºÐ¼®¿¬±¸¿ø ä¿ë (Áõ¿ø)
ÃæºÏ Áøõ±º | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.12 |
|
|
¿ÀÄÉÀ̸޵ð³ÝÄÚ¸®¾Æ(ÁÖ) |
ÀÇ·á±â±â ÀÎÇã°¡/Ç°Áú°ü¸® °æ·ÂÀÚ ¸ðÁý
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
2³â¡è |
ä¿ë½Ã |
12.18 |
|
|
(ÁÖ)½´¾î¾î½Ã½ºÆ® |
[½´¾î¾î½Ã½ºÆ®] Á¦¾àȸ»ç Àû°Ý¼ºÆò°¡ Àοø ¸ðÁý(¿Ü±Ù°¡´ÉÀÚ
°æ±â Àǿսà | ´ëÇÐ(2~3³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
°æ·Â¹«°ü |
ä¿ë½Ã |
07.19 |
|
|
³ëÀ» ÁÖ½Äȸ»ç |
°³¹ß QA
°æ±â ¿ëÀνà | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
2³â¡è |
ä¿ë½Ã |
04.17 |
|
|
°æ¹æ½Å¾à(ÁÖ) |
ÀϹݽÄÇ°, °Ç°±â´É½ÄÇ° Ç°Áú°ü¸® °æ·Âä¿ë
Ãæ³² ±Ý»ê±º | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.06 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Quality Associate
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
3³â¡è |
ä¿ë½Ã |
02.12 |
|
|
´õºíÀ¯¸ÞµðÄ®(W-medical) |
[±Þ±¸] ÀÇ·á±â±â Ç°ÁúÃ¥ÀÓÀÚ Á¤±ÔÁ÷ ä¿ë (°æ·Â)
°æ±â ³²¾çÁֽà | °íµîÇб³ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
1³â¡è |
ä¿ë½Ã |
02.21 |
|
|
(ÁÖ)¼¿ïÁ¦¾à |
Ç°Áú°ü¸® °æ·Âä¿ë
ÃæºÏ ûÁֽà Èï´ö±¸ | Çз¹«°ü |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.26 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Quality Associate
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
3³â¡è |
ä¿ë½Ã |
02.17 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Clinical Study Unit Quality Lead (CSU QL
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
5³â¡è |
ä¿ë½Ã |
05.26 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Quality Associate
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
3³â¡è |
ä¿ë½Ã |
02.17 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Quality Associate
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
3³â¡è |
ä¿ë½Ã |
02.21 |
|